In this month's issue of the freely available online journal PLoS Medicine
, Dr. Thomas N. Williams and colleagues from Kilifi, Kenya, show that the protection against malaria given by carrying the gene for sickle cell haemoglobin may involve the immune system. Studying a group of children and adults in the Kilifi District of coastal Kenya, they found that this protection increased during childhood up to age 10, and then declined.
It is estimated that cases of malaria causes approximately a million deaths yearly, the overwhelming number of which are young children in sub-Saharan Africa. It has been known for many years that in those areas most afflicted by malaria the gene for sickle cell hemoglobin (HbS) occurs very frequently. The protection against malaria occurs in people who are heterozygote (HbAS), i.e., have one normal and one sickle gene, and previous work has suggested that there is an immune component to this protection.
To discover whether the protection provided by HbAS is innate or varies with age, the authors studied age-specific malaria in a sample of children and adults in the Kilifi District of coastal Kenya. Protection against mild malaria increased up to 60% at age 10, decreasing to 30% in older children.
Research into malaria has yet to yield an effective vaccine but this work may provide some insights for such research. The authors suggest mechanisms by which HbAS could affect immunity, for example, accelerated acquisition of antibodies to altered host proteins expressed on the malaria-infected red cell surface.
Page: 1 Related medicine news :1
Contact: Paul Ocampo
Public Library of Science
. National Academies Advisory -- June 8 public briefing on LANL groundwater protection2
. Vaxfectin-formulated measles DNA vaccine elicits long-term protection in nonhuman primates3
. Erectile dysfunction drugs may trump nitroglycerin for heart protection4
. IEEE-USA launches critical infrastructure protection committee5
. Law professor finds home health-care workers have few legal protections6
. Live H5N1 avian flu virus vaccines show protection in animal studies7
. Combined therapies may boost immune response and long-term protection against brain tumors8
. New radiation protection technique results in reduced physician exposure9
. Antioxidant selenium offers no heart-disease protection10
. Trial shows vaccine against cervical cancer provides long-term protection11
. High good cholesterol trumps low bad cholesterol for heart protection